Eleos’ AI Agents Transforming Behavioral Health Raises $60M Series C

AI agents are transforming industries by automating routine processes, providing data-driven insights, and supporting decision-making. Five-year-old startup Eleos Health is focusing on the behavioral health sector, leading the charge with AI agents in an industry burdened by administrative challenges, inefficiencies, and limited access to care.

Alon Joffe , Eleos’ Co-Founder and CEO, emphasizes that the goal of the company’s AI agents is to empower clinicians, not replace them. “From day one, Eleos has been committed to empowering clinicians—by freeing up their time from tedious administrative work so they can focus on delivering better care,” Joffe said. The company designed its platform to complement, not replace, the critical work done by clinicians.

Joffe and his co-founders Dror Zaide , Shiri Sharvit, PhD , and Alon Rabinovich combined their skills and experience to launch the healthcare tech Startup. The startup’s rapid growth has gained additional support from investors with the company closing a Series C funding round.

The Power of AI Agents in Behavioral Health

Eleos’ AI agents fundamentally change the workflow of behavioral health practitioners, improving time-consuming tasks such as clinical documentation, compliance monitoring, and patient engagement. These changes are allowing healthcare providers to spend more time with patients and less on paperwork.

Eleos’ AI technology has shown a proven ability to improve both clinical outcomes and operational efficiency. A recent randomized controlled trial (RCT) demonstrated that Eleos reduced progress note submission times by over 80%, while also doubling client engagement and improving patient care outcomes by 3–4 times compared to traditional methods.

AI Agents as a Tool for Providers

One of Eleos’ most recent product launches, Eleos Compliance, leverages AI agents, reviewing progress notes in real-time, and flagging potential errors before they lead to costly fines or payment claw-backs. Time-consuming appeals are reduced and organizations better comply with legal and regulatory requirements.

By leveraging multimodal, large language models (MM-LLMs), Eleos’ platform handles at one time various forms of data, processing information from different sources such as patient conversations, clinical notes, and assessments, ensuring a more holistic approach to patient care.

A Rapidly Expanding Market Offers Opportunity

Eleos’ rapid growth trajectory is reflected through its over 120 customer organizations across 30 states in the U.S., becoming the most widely deployed enterprise-grade AI platform in behavioral health.

The company’s recent $60 million Series C round, led by Greenfield Partners , with participation from notable investors like F-Prime , Menlo Ventures , and the Michael & Susan Dell Foundation , will accelerate Eleos’ innovative use of artificial intelligence (AI) agents to transform the delivery of behavioral health services.

With more than $120 million in funding in place, Eleos will expand into underserved markets, particularly substance use disorder (SUD) treatment centers and post-acute behavioral healthcare settings.

The post-acute behavioral healthcare market is a key focus for Eleos in its mission to enhance the accessibility and effectiveness of mental health services. Valued at $11 billion, this sector has historically faced underinvestment from health tech, leaving a gap in the availability of innovative solutions to improve care.

In addition to expanding into new markets, Eleos will continue to develop AI-driven products and strengthen its engineering team. The company continues its focus on offering innovative solutions that can scale to meet the needs of the behavioral health sector.

A Strong Partnership with Greenfield Partners

Shay Grinfeld , Managing Partner at Greenfield Partners, expressed his enthusiasm about Eleos’ mission to reshape the behavioral health industry. “Eleos’ transformative product alleviates the overwhelming administrative burden faced by providers, empowering them to focus on delivering exceptional care,” Grinfeld said. “We are excited to be part of their journey.”

The backing from Greenfield and other prominent investors reflects the growing recognition of the importance of AI in improving healthcare delivery, particularly in the behavioral health space, which is now ready for technological innovation.

The Future of Behavioral Health in the Healthcare Technology Sector

AI agents have become crucial in today’s AI world because of their ability to streamline tasks, enhance productivity, and solve complex problems.

Eleos’ commitment to AI-driven healthcare, coupled with its focus on empowering providers rather than replacing them, positions the company as a leader in the behavioral health space. With its rapid growth, innovative solutions, and ongoing investment in cutting-edge technology, Eleos is well on its way to fulfilling its mission to transform behavioral health.